ALUNBRIG® (brigatinib) Expert Opinion Video Series: Managing cardiac adverse events, including bradycardia and hypertension, associated with ALUNBRIG

Listen to Dr Sharmistha Ghosh discuss the management of cardiac adverse events, including bradycardia and hypertension, which may be experienced in patients with ALK+ aNSCLC who take ALUNBRIG.

Dr Ghosh explains the recommended dose modifications for ALUNBRIG in cases of bradycardia and hypertension, as well as her clinical experience of managing these adverse events.

ALK+, anaplastic lymphoma kinase positive; aNSCLC, advanced non-small cell lung cancer.